newsfilter
← Latest News
GlobeNewswire·

iRhythm Announces Approval of $200 Million Share Repurchase Program

  • iRhythm Holdings, Inc. announced its Board of Directors approved a share repurchase program authorizing the purchase of up to $200 million of outstanding common stock on November 10, 2026.
  • The approval reflects confidence in iRhythm's core business strength & growth opportunities from the recently acquired VitalConnect business.
  • Repurchases may be executed via open market transactions, privately negotiated deals, accelerated share repurchase transactions, or other methods based on market conditions & corporate needs.
  • Open market repurchases will comply with federal & state securities laws, including Rule 10b-18 pricing & volume conditions, & the company may utilize Rule 10b5-1 plans.
  • The program does not obligate the company to repurchase any specific dollar amount or number of shares & may be modified, suspended, or terminated at the Board's discretion.
  • iRhythm expects to fund repurchases using existing cash, cash equivalents, & ongoing cash from operations.
Company
iRhythm
Keywords
Nasdaq:IRTC, iRhythm